Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.0
7.8
Journals
Vaccines
Special Issues
The Effect of Influenza Vaccination on Chronic Disease
share announcement

The Effect of Influenza Vaccination on Chronic Disease

A special issue of Vaccines (ISSN 2076-393X).

Deadline for manuscript submissions: 31 August 2024 | Viewed by 1620

Special Issue Editors

Prof. Dr. Ju-Chi Liu

E-Mail Website
Guest Editor
Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan
Interests: atherosclerosis; hypertension; molecular biology in cardiovascular systems
Special Issues, Collections and Topics in MDPI journals
Dr. Wen-Rui Hao

E-Mail Website
Guest Editor
Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan
Interests: coronary artery disease; molecular biology in cardiovascular systems; heart failure
Special Issues, Collections and Topics in MDPI journals
Dr. Chun-Chao Chen

E-Mail Website
Guest Editor
Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan
Interests: coronary artery disease; electrophysiology; heart failure
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The impact of influenza vaccination on reducing the risk of influenza virus infection has been well-documented. In addition to protecting against infection, the vaccine can significantly lower the risk of mortality and other complications associated with the virus, making it highly recommended, especially for high-risk populations such as the elderly, patients with chronic diseases, and healthcare providers. While research has demonstrated other potential benefits of influenza vaccination, detailed clinical data and mechanisms supporting its additional effects among patients with chronic diseases are still lacking. 

By gaining a deeper understanding of the protective benefits of the influenza vaccine beyond infection prevention, we can further improve the long-term outcomes of patients with chronic diseases. Therefore, we invite you to submit research articles on the effectiveness and potential mechanisms of the influenza vaccine in this population. We welcome the submission of clinical observational studies, randomized control trials, and basic molecular/animal investigations.

Prof. Dr. Ju-Chi Liu
Dr. Wen-Rui Hao
Dr. Chun-Chao Chen
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • influenza vaccine
  • chronic disease
  • cancer
  • pleiotropic effect
  • cardiovascular disease
  • arrythmia

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

10 pages, 264 KiB  
Article
Impact of Actively Offering Influenza Vaccination to Frail People during Hospitalisation: A Pilot Study in Italy
by Alessandra Fallucca, Patrizia Ferro, Luca Mazzeo, Luigi Zagra, Elena Cocciola, Roberta Oliveri, Antonino Tuttolomondo, Alida Benfante, Salvatore Battaglia, Nicola Scichilone, Nicola Veronese, Marco Affronti, Mario Barbagallo, Alessandra Casuccio, Francesco Vitale, Vincenzo Restivo and the AOUP Inpatient Vaccination Team
Vaccines 2023, 11(12), 1829; https://doi.org/10.3390/vaccines11121829 - 08 Dec 2023
Viewed by 1375
Abstract
Despite the worldwide recommendations for influenza immunisation, vaccination coverage for patients exposed to the highest risk of severe complications is still far from the optimal target. The need to take advantage of alternative methods to provide vaccination is essential. This study presents a [...] Read more.
Despite the worldwide recommendations for influenza immunisation, vaccination coverage for patients exposed to the highest risk of severe complications is still far from the optimal target. The need to take advantage of alternative methods to provide vaccination is essential. This study presents a hospital-based strategy which offers influenza vaccination to inpatients at discharge. This study was conducted during the 2022–2023 influenza season at the University Hospital of Palermo. A questionnaire was administered to identify the determinants for the acceptance of influenza vaccination in the frail population. Overall, 248 hospitalised patients were enrolled, of which 56.1% were female and 52.0% were over 65 years of age. The proportion of patients vaccinated against influenza during hospitalisation was 62.5%, an increase of 16% in influenza vaccination uptake among frail people in comparison with the previous influenza season (46.8% vaccinated during the 2021–22 influenza season). Factors significantly associated with vaccination acceptance were the following: to have received influenza vaccine advice from hospital healthcare workers (OR = 3.57, p = 0.001), to have been previously vaccinated for influenza (OR = 3.16 p = 0.005), and to have had a low level of education (OR = 3.56, p = 0.014). This study showed that offering influenza vaccination to hospitalised patients could be an effective strategy to increase vaccination coverage in the most vulnerable population, and these findings could be useful for planning and improving future influenza vaccination campaigns. Full article
(This article belongs to the Special Issue The Effect of Influenza Vaccination on Chronic Disease)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop